Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.16 - $0.31 $7,162 - $13,877
44,765 Added 5104.33%
45,642 $6,000
Q2 2022

Aug 15, 2022

SELL
$0.24 - $1.2 $1,995 - $9,976
-8,314 Reduced 90.46%
877 $0
Q1 2022

May 16, 2022

SELL
$0.94 - $2.38 $12,222 - $30,947
-13,003 Reduced 58.59%
9,191 $11,000
Q4 2021

Feb 14, 2022

SELL
$1.89 - $3.12 $10,582 - $17,468
-5,599 Reduced 20.15%
22,194 $58,000
Q3 2021

Nov 15, 2021

BUY
$2.34 - $3.77 $9,437 - $15,204
4,033 Added 16.97%
27,793 $64,000
Q2 2021

Aug 16, 2021

BUY
$3.48 - $4.45 $82,684 - $105,732
23,760 New
23,760 $87,000

Others Institutions Holding QTNT

# of Institutions
1
Shares Held
1.71K
Call Options Held
0
Put Options Held
0

About Quotient Ltd


  • Ticker QTNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Description
  • Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological di...
More about QTNT
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.